» Articles » PMID: 38318248

Evaluation of Recombinant Baculovirus Clearance During RAAV Production in Sf9 Cells Using a Newly Developed Fluorescent-TCID Assay

Overview
Specialty General Medicine
Date 2024 Feb 6
PMID 38318248
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Recombinant adeno-associated virus (rAAV) vectors provide a safe and efficient means for gene delivery, although its large-scale production remains challenging. Featuring high manufacturing speed, flexible product design, and inherent safety and scalability, the baculovirus/Sf9 cell system offers a practical solution to the production of rAAV vectors in large quantities and high purity. Nonetheless, removal and inactivation of recombinant baculoviruses during downstream purification of rAAV vectors remain critical prior to clinical application.

Methods: The present study utilized a newly developed fluorescent-TCID (F-TCID) assay to determine the infectious titer of recombinant baculovirus (rBV) stock after baculovirus removal and inactivation, and to evaluate the impact of various reagents and solutions on rBV infectivity.

Results And Discussion: The results showed that a combination of sodium lauryl sulfate (SLS) and Triton X-100 lysis, AAVx affinity chromatography, low pH hold (pH3.0), CsCl ultracentrifugation, and NFR filtration led to effective removal and/or inactivation of recombinant baculoviruses, and achieved a log reduction value (LRV) of more than 18.9 for the entire AAV purification process. In summary, this study establishes a standard protocol for downstream baculovirus removal and inactivation and a reliable F-TCID assay to detect rBV infectivity, which can be widely applied in AAV manufacturing using the baculovirus system.

References
1.
Papanikolaou E, Bosio A . The Promise and the Hope of Gene Therapy. Front Genome Ed. 2021; 3:618346. PMC: 8525363. DOI: 10.3389/fgeed.2021.618346. View

2.
Maghodia A, Jarvis D . Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines. Virology. 2017; 512:234-245. PMC: 5651996. DOI: 10.1016/j.virol.2017.09.025. View

3.
Ma H, Galvin T, Glasner D, Shaheduzzaman S, Khan A . Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines. J Virol. 2014; 88(12):6576-85. PMC: 4054387. DOI: 10.1128/JVI.00780-14. View

4.
Felberbaum R . The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnol J. 2015; 10(5):702-14. PMC: 7159335. DOI: 10.1002/biot.201400438. View

5.
Wang D, Tai P, Gao G . Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019; 18(5):358-378. PMC: 6927556. DOI: 10.1038/s41573-019-0012-9. View